The results from Pfizer's vaccine trial and what they tell us

The vaccine is being rolled out in a number of countries. Image: REUTERS/Carlos Osorio

Anne Moore
Senior Lecturer in Biochemistry and Cell Biology, University College Cork
Our Impact
The Big Picture
Explore and monitor how Vaccination is affecting economies, industries and global issues
Crowdsource Innovation
Get involved with our crowdsourced digital platform to deliver impact at scale
Stay up to date:


Have you read?
An elderly woman receives a coronavirus vaccine in a care home in Scotland
In the UK, the vaccine is first being given to older care residents, people over 80 and health and social care workers. Image: Russell Cheyne/PA Wire
Vaccination COVID-19 Pandemic Preparedness and Response
The safety profile of the vaccine is good – across different ages, ethnicities and both sexes. Image: The New England Journal of Medicine
Don't miss any update on this topic

Create a free account and access your personalized content collection with our latest publications and analyses.

License and Republishing

World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

The views expressed in this article are those of the author alone and not the World Economic Forum.

Related topics:
VaccinationCOVID-19Pandemic Preparedness and Response
Global Agenda

The Agenda Weekly

A weekly update of the most important issues driving the global agenda

Subscribe today

You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.

Measles: Why the World Health Organization has declared it an ‘imminent global threat’

Michael Head

December 13, 2022

About Us



Partners & Members

  • Join us

Language Editions

Privacy Policy & Terms of Service

© 2023 World Economic Forum